Useful resources |
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism (Cochrane Review) ABSTRACT Background: Currently, the most frequently used secondary treatment for patients with venous thromboembolism is vitamin K antagonists targeted at an INR of 2.5 (range 2.0 to 3.0). However, based on the continuing risk of bleeding and uncertainty regarding the ri . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |